摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(5aR,10aR)-tetrahydro-3H,5H,8H,10H-bisthiazolo<3,4-a:3',4'-d>pyrazine-5,10-dione | 72744-67-3

中文名称
——
中文别名
——
英文名称
(5aR,10aR)-tetrahydro-3H,5H,8H,10H-bisthiazolo<3,4-a:3',4'-d>pyrazine-5,10-dione
英文别名
(5aR,10aR)-tetrahydrodithiazolo[3,4-a:3’,4’-d]pyrazine-5,10(3H,8H)-dione;cyclo[L-Thz-L-Thz];(5aR)-(5ar,10ac)-tetrahydro-bisthiazolo[3,4-a;3',4'-d]pyrazine-5,10-dione;N,S;N',S'-di-methanediyl-cyclo-(L-cysteinyl->L-cysteinyl);(5aR,10aR)-Tetrahydrodithiazolo[3,4-a:3',4'-d]pyrazine-5,10(3H,8H)-dione;(3R,9R)-5,11-dithia-1,7-diazatricyclo[7.3.0.03,7]dodecane-2,8-dione
(5aR,10aR)-tetrahydro-3H,5H,8H,10H-bisthiazolo<3,4-a:3',4'-d>pyrazine-5,10-dione化学式
CAS
72744-67-3
化学式
C8H10N2O2S2
mdl
——
分子量
230.312
InChiKey
IBBKEOUUWVDDIT-WDSKDSINSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    166 - 170°C
  • 密度:
    1.62
  • 溶解度:
    氯仿(微溶)、甲醇(微溶、超声处理)、二氯甲烷

计算性质

  • 辛醇/水分配系数(LogP):
    0.2
  • 重原子数:
    14
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    91.2
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    (5aR,10aR)-tetrahydro-3H,5H,8H,10H-bisthiazolo<3,4-a:3',4'-d>pyrazine-5,10-dione 在 sodium tetrahydroborate 、 四氯化钛 作用下, 以 乙二醇二甲醚 为溶剂, 反应 8.42h, 以39%的产率得到(6R,8aR)-7-methyl-6-(sulfanylmethyl)-thiazolidine[3,4-a]piperazine
    参考文献:
    名称:
    从 L-半胱氨酸及其第一镍配合物开始合成手性多齿配体系统
    摘要:
    从受保护的 L-半胱氨酸出发,可以合成 2, 5-二酮哌嗪 V,用 NaBH4/TiCl4 将其还原生成 (6R,8aR)-7-methyl-6-(sulfanylmethyl)-thiazolidine [3,4- a] 哌嗪,L1H 以及 N,N'-二甲基-(2R,5R)-双(硫烷基甲基)哌嗪,L2H2,它们被分离和表征。L2H2 可以选择性地获得,如果 V 在 DIEA·HCl 存在下被 NaBH4/TiCl4 还原,它代表了一种新型手性配体的前体,因为在去质子化后它提供了两个硫醇基和两个氨基供体功能,用于配位一个金属原子。L1H 和 L2H2 用 NaOMe 去质子化,然后用 NiBr2(dme) 处理,分别导致二聚体配合物 [L1NiBr]2 (1) 和 [L2Ni]2 (2) 的分离。两者都得到了充分的表征,
    DOI:
    10.1002/zaac.201300071
  • 作为产物:
    参考文献:
    名称:
    Anti-biofilm and anti-adherence properties of novel cyclic dipeptides against oral pathogens
    摘要:
    Microorganisms embedded in a biofilm are significantly more resistant to antimicrobial agents and the defences of the human immune system, than their planktonic counterpart. Consequently, compounds that can inhibit biofilm formation are of great interest for novel therapeutics. In this study, a screening approach was used to identify novel cyclic dipeptides that have anti-biofilm activity against oral pathogens. Five new active compounds were identified that prevent biofilm formation by the cariogenic bacterium Streptococcus mutans and the pathogenic fungus Candida albicans. These compounds also inhibit the adherence of microorganisms to a hydroxylapatite surface. Further investigations were conducted on these compounds to establish the structure-activity relationship, and it was deduced that the common cleft pattern is required for these molecules to act effectively against biofilms.
    DOI:
    10.1016/j.bmc.2018.11.042
点击查看最新优质反应信息

文献信息

  • Synthesis and structural study of piperazine-2,5-diones derived from (R)-cysteine
    作者:Asensio González、Svetlana L. Vorob́eva、Ana Linares
    DOI:10.1016/0957-4166(95)00168-o
    日期:1995.6
    Coupling Leuch's anhydrides obtained from (R)-thiazolidine-4-carboxylic acids 1 and 3 with one equivalent of the corresponding ethyl ester derivative of 1 or 3, leads to the formation of chiral piperazine-2,5-diones 2, 4, 5, 6, and 7, on thermal treatment of the intermediate dipeptides. The configuration of the products was established by nOe experiments.
    从(R) -噻唑烷-4-羧酸的耦合而获得Leuch的酸酐1和3与一当量的相应的乙酯衍生物的1或3,导致手性哌嗪-2,5-二酮的形成2,4,5 ,6和7,是关于中间二肽的热处理的。通过nOe实验确定了产品的配置。
  • Interfacial supramolecular biomimetic epoxidation catalysed by cyclic dipeptides
    作者:Christopher Bérubé、Xavier Barbeau、Sébastien Cardinal、Pierre-Luc Boudreault、Corinne Bouchard、Nicolas Delcey、Patrick Lagüe、Normand Voyer
    DOI:10.1080/10610278.2016.1236197
    日期:2017.5.4
    We synthesised a library of cis- and trans-cyclic dipeptides and evaluated their efficacy as catalysts in the asymmetric Weitz-Scheffer epoxidation of trans-chalcone. A thorough investigation relying on structure-activity studies and computational studies provided insights into the mechanism of the process. Our results revealed some structural features required for efficient conversion and for introduction of chirality into the product. The cyclic dipeptide acts as a catalyst by templating a supramolecular arrangement at the aqueous-organic interface required for efficient transformations to occur. Among all cyclic dipeptides investigated, cyclo(Leu-Leu) was the most efficient supramolecular catalyst.[GRAPHICS].
  • Diketopiperazines from optically active thiazolidine-4-carboxylic acids
    作者:Z. Gy�rgyde�k、Z. Dinya、R. Bogn�r
    DOI:10.1007/bf00473841
    日期:1979.9
  • A straightforward synthesis and partial hydrolysis of cysteine-derived 2,5-diketopiperazines
    作者:Daniela Iannotta、Nicola Castellucci、Magda Monari、Claudia Tomasini
    DOI:10.1016/j.tetlet.2010.06.108
    日期:2010.8
    A mild and straightforward preparation of cysteine-derived 2,5-diketopiperazines (DKPs) is reported, by cyclization of (R)-2,2-dimethyltetrahydrothiazole-4-carboxylic acid hydrochloride or of (R)-tetrahydrothiazole-4-carboxylic acid hydrochloride, mediated by HBTU and DIEA. One DKP has been characterized by X-ray analysis, while the other has been hydrolyzed to cyclo-Cys-Cys. The preparation of this latter compound has been previously reported to be troublesome and low yielding. (C) 2010 Elsevier Ltd. All rights reserved.
  • DERDDEHAK Z.; DINYA Z.; BOGNAR R., XIMIYA GETEROTSIKL. SOEDIN., 1979, HO 9, 1211-1220
    作者:DERDDEHAK Z.、 DINYA Z.、 BOGNAR R.
    DOI:——
    日期:——
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物